NLS Pharmaceutics Ltd. -CW25NLSPWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders −2
0new positions
2sold out
1famous investor
$0.01avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding NLS Pharmaceutics Ltd. -CW25 (NLSPW) in their 13F filings, down 2 from Q4 2024. 0 opened new positions and 2 sold out. The largest holders were Clear Street LLC ($744), Citadel Advisors ($237) and Armistice Capital, LLC ($161). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- NLS Pharmaceutics Ltd. -CW25
- CUSIP
- H57830111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $4K |
All 13F filers, Q4 2024 → Q1 2025: 317,233 shares sold, net −317,233 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Clear Street LLC | — | Reduce -0.5% | 57,642 | $744 |
| Citadel Advisors | — | Reduce -3.0% | 18,381 | $237 |
| Armistice Capital, LLC | — | No change | 12,500 | $161 |
"% of holder's portfolio" is NLSPW's weight in each manager's 13F, not the share of NLS Pharmaceutics Ltd. -CW25 the manager owns.